Detection of Chromosomal and Plasmid-Mediated Quinolone Resistance Among Escherichia coli Isolated from Urinary Tract Infection Cases; Zagazig University Hospitals, Egypt
- PMID: 32104013
- PMCID: PMC7023874
- DOI: 10.2147/IDR.S240013
Detection of Chromosomal and Plasmid-Mediated Quinolone Resistance Among Escherichia coli Isolated from Urinary Tract Infection Cases; Zagazig University Hospitals, Egypt
Abstract
Introduction: Resistance to fluoroquinolones (FQ) in uropathogenic Escherichia coli (UPEC) has emerged as a growing problem. Chromosomal mutations and plasmid-mediated quinolone resistance (PMQR) determinants have been implicated. Data concerning the prevalence of these determinants in UPEC in our hospital are quite limited.
Purpose: To investigate the occurrence and genetic determinants of FQ resistance in UPEC isolated from urinary tract infection (UTI) cases in Zagazig University Hospitals.
Patients and methods: Following their isolation, the identification and susceptibility of UPEC isolates were performed by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometer (MALDI-TOF MS). FQ resistance was detected by the disc diffusion method. Ciprofloxacin minimal inhibitory concentration (MIC) was determined using E-test. Chromosomal mutations in the gyrA gene were detected using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and for detection of PMQR, a couple of multiplex PCR reactions were used.
Results: Among a total of 192 UPEC isolates, 46.9% (n=90) were FQ resistant. More than half of the isolates (57.8%) exhibited high-level ciprofloxacin resistance (MIC > 32 µg/mL). Mutations in gyrA were detected in 76.7% of isolates, with 34.4% having mutations at more than one site. PMQR determinants were detected in 80.1% of UPEC isolates, with aac(6')-Ib-cr gene being the most frequent found in 61.1% of isolates.
Conclusion: There is a high prevalence of both gyrA mutations and PMQR determinants among UPEC isolates in our hospital which contribute to high-level ciprofloxacin resistance, a finding that may require the revision of the antibiotics used for empirical treatment of UTI.
Keywords: ciprofloxacin resistance; gyrA mutations; qnr determinants; uropathogenic E. coli.
© 2020 Esmaeel et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Quinolone-resistant uropathogenic E. coli: is there a relation between qnr genes, gyrA gene target site mutation and biofilm formation?J Med Microbiol. 2021 Oct;70(10). doi: 10.1099/jmm.0.001432. J Med Microbiol. 2021. PMID: 34665111
-
Determination of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infection in Iran.J Glob Antimicrob Resist. 2018 Jun;13:197-200. doi: 10.1016/j.jgar.2018.04.017. Epub 2018 May 7. J Glob Antimicrob Resist. 2018. PMID: 29747008
-
The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.Infect Genet Evol. 2020 Aug;82:104319. doi: 10.1016/j.meegid.2020.104319. Epub 2020 Apr 8. Infect Genet Evol. 2020. PMID: 32278145
-
Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.J Glob Antimicrob Resist. 2019 Jun;17:39-43. doi: 10.1016/j.jgar.2018.11.003. Epub 2018 Nov 13. J Glob Antimicrob Resist. 2019. PMID: 30445211
-
Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.Int J Antimicrob Agents. 2015 Mar;45(3):238-43. doi: 10.1016/j.ijantimicag.2014.09.019. Epub 2014 Nov 13. Int J Antimicrob Agents. 2015. PMID: 25468717
Cited by
-
Investigation of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in Klebsiella pneumoniae clinical isolates.BMC Microbiol. 2024 Jul 18;24(1):265. doi: 10.1186/s12866-024-03383-5. BMC Microbiol. 2024. PMID: 39026143 Free PMC article.
-
Characterization of Integrons and Quinolone Resistance in Clinical Escherichia coli Isolates in Mansoura City, Egypt.Int J Microbiol. 2021 Sep 4;2021:6468942. doi: 10.1155/2021/6468942. eCollection 2021. Int J Microbiol. 2021. PMID: 34527054 Free PMC article.
-
Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae.Antibiotics (Basel). 2021 Apr 20;10(4):469. doi: 10.3390/antibiotics10040469. Antibiotics (Basel). 2021. PMID: 33924153 Free PMC article.
-
Burden of Fluoroquinolone Resistance in Clinical Isolates of Escherichia coli at the Ho Teaching Hospital, Ghana.Ethiop J Health Sci. 2022 Jan;32(1):93-102. doi: 10.4314/ejhs.v32i1.11. Ethiop J Health Sci. 2022. PMID: 35250221 Free PMC article.
-
Determination of antibiotic resistance patterns and genotypes of Escherichia coli isolated from wild birds.Microbiome. 2024 Jan 8;12(1):8. doi: 10.1186/s40168-023-01729-1. Microbiome. 2024. PMID: 38191447 Free PMC article.
References
LinkOut - more resources
Full Text Sources